Pharming Group NV (PHAR)
10.55
-0.27
(-2.50%)
USD |
NASDAQ |
Sep 15, 16:00
10.46
-0.09
(-0.85%)
Pre-Market: 20:00
Pharming Group Market Cap : 746.71M for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 746.71M |
| September 14, 2026 | 765.82M |
| September 11, 2026 | 793.42M |
| September 10, 2026 | 764.76M |
| September 09, 2026 | 776.44M |
| September 08, 2026 | 813.95M |
| September 04, 2026 | 794.84M |
| September 03, 2026 | 811.12M |
| September 02, 2026 | 792.71M |
| September 01, 2026 | 786.34M |
| August 31, 2026 | 812.53M |
| August 28, 2026 | 828.10M |
| August 27, 2026 | 833.77M |
| August 26, 2026 | 845.80M |
| August 25, 2026 | 833.06M |
| August 24, 2026 | 811.12M |
| August 21, 2026 | 838.72M |
| August 20, 2026 | 826.69M |
| August 19, 2026 | 838.72M |
| August 18, 2026 | 842.97M |
| August 17, 2026 | 834.47M |
| August 14, 2026 | 829.52M |
| August 13, 2026 | 874.11M |
| August 12, 2026 | 837.30M |
| August 11, 2026 | 865.62M |
| Date | Value |
|---|---|
| August 10, 2026 | 803.33M |
| August 07, 2026 | 775.02M |
| August 06, 2026 | 767.94M |
| August 05, 2026 | 755.56M |
| August 04, 2026 | 726.18M |
| August 03, 2026 | 695.04M |
| July 31, 2026 | 713.44M |
| July 30, 2026 | 760.86M |
| July 29, 2026 | 850.04M |
| July 28, 2026 | 910.21M |
| July 27, 2026 | 912.74M |
| July 24, 2026 | 884.82M |
| July 23, 2026 | 923.75M |
| July 22, 2026 | 909.02M |
| July 21, 2026 | 920.59M |
| July 20, 2026 | 919.54M |
| July 17, 2026 | 944.79M |
| July 16, 2026 | 932.17M |
| July 15, 2026 | 939.88M |
| July 14, 2026 | 940.93M |
| July 13, 2026 | 965.83M |
| July 10, 2026 | 972.15M |
| July 09, 2026 | 984.77M |
| July 08, 2026 | 1.003B |
| July 07, 2026 | 1.014B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 259.66M |
| NewAmsterdam Pharma Co. NV | 2.490B |
| argenx SE | 60.63B |
| DBV Technologies SA | 695.99M |
| ACADIA Pharmaceuticals, Inc. | 4.606B |
Market Cap Related Metrics
| PE Ratio | 84.88 |
| PS Ratio | 2.121 |
| Price to Book Value | 2.905 |
| Price to Free Cash Flow | 30.22 |
| Price | 10.55 |
| Earnings Yield | 1.18% |
| Operating PE Ratio | 34.75 |
| Normalized PE Ratio | 47.35 |